Multicenter retrospective analysis of Elotuzumab, lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Not Applicable
- Conditions
- multiple myeloma
- Registration Number
- JPRN-UMIN000042502
- Lead Sponsor
- Japan Red Cross Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Cases received ERd as clinical trial.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall response rate, very good partial response rate, complete response rate
- Secondary Outcome Measures
Name Time Method progression free survival overall survival time to nexuses treatment